| Date Filed | Type | Description |
| 10/13/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/09/2023 |
SC 13D/A
| New Enterprise Associates 14, L.P. has filed a Schedule 13D for Oyster Point Pharma, Inc. |
| 11/21/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/12/2022 |
SC 13D
| New Enterprise Associates 14, L.P. reports a 15.3% stake in ZeroFox Holdings, Inc. |
| 05/24/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/25/2022 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 7.3% stake in IMARA Inc. |
| 02/15/2022 |
SC 13G
| New Enterprise Associates 14, L.P. reports a 29.5% stake in Tuya, Inc. |
| 01/10/2022 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 14.1% stake in IMARA Inc. |
| 01/05/2022 |
SC 13D/A
| New Enterprise Associates 14, L.P. has filed a Schedule 13D for Lumos Pharma, Inc. |
| 12/01/2021 |
SC 13D
| New Enterprise Associates 14, L.P. reports a 8.6% stake in NextNav Inc. |
| 11/22/2021 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 15% stake in Casper Sleep Inc. |
| 03/10/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/10/2020 |
SC 13D/A
| New Enterprise Associates 14, L.P. has filed a Schedule 13D for Mersana Therapeutics, Inc. |
| 11/19/2020 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 5.8% stake in Mersana Therapeutics, Inc. |
| 09/21/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/24/2020 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 12.9% stake in Mersana Therapeutics, Inc. |
| 03/31/2020 |
SC 13D
| New Enterprise Associates 14, L.P. reports a 6.3% stake in Lumos Pharma, Inc. |
| 03/20/2020 |
SC 13D
| New Enterprise Associates 14, L.P. reports a 24.2% stake in IMARA Inc. |
| 02/20/2020 |
SC 13D
| New Enterprise Associates 14, L.P. reports a 15.7% stake in Casper Sleep Inc. |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G
| New Enterprise Associates 14, L.P. reports a 17.6% stake in Galera Therapeutics, Inc. |
| 02/13/2020 |
SC 13G/A
| New Enterprise Associates 14, L.P. has filed a Schedule 13D for Elastic N.V. |
| 11/07/2019 |
SC 13D
| New Enterprise Associates 14, L.P. reports a 28.7% stake in Oyster Point Pharma, Inc. |
| 02/13/2019 |
SC 13G
| New Enterprise Associates 14, L.P. reports a 9% stake in Elastic N.V. |
| 02/13/2019 |
SC 13G
| New Enterprise Associates 14, L.P. reports a 12% stake in Surface Oncology, Inc. |
| 02/12/2019 |
SC 13G/A
| New Enterprise Associates 14, L.P. has filed a Schedule 13D for Appian Corporation |
| 09/17/2018 |
SC 13D
| New Enterprise Associates 14, L.P. reports a 15.7% stake in Adaptimmune Therapeutics Plc |
| 05/14/2018 |
SC 13D/A
| New Enterprise Associates 14, L.P. has filed a Schedule 13D for MuleSoft, Inc. |
| 04/03/2018 |
SC 13D/A
| New Enterprise Associates 14, L.P. reports a 20% stake in Tracon Pharmaceuticals, Inc. |
| 03/29/2018 |
SC 13D
| New Enterprise Associates 14, L.P. reports a 15.3% stake in MuleSoft, Inc. |
| 02/12/2018 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
|